1 / 55

Glasgow Junior Academic Forum

Glasgow Junior Academic Forum. G-JAF. Terry Quinn t.j.quinn@clinmed.gla.ac.uk Cardiovascular & Medical Sciences University of Glasgow Sponsored through an unrestricted educational grant. Glasgow Junior Academic Forum. WHY To provide a forum for discussion of current and future research.

teige
Télécharger la présentation

Glasgow Junior Academic Forum

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Glasgow Junior Academic Forum G-JAF Terry Quinn t.j.quinn@clinmed.gla.ac.uk Cardiovascular & Medical Sciences University of Glasgow Sponsored through an unrestricted educational grant

  2. Glasgow Junior Academic Forum WHY • To provide a forum for discussion of current and future research. • To allow junior academics to network with each other and more senior colleagues. • To facilitate development of research presentation skills. • To provide a forum for informal teaching on research strategies and advice on succeeding in the academic sphere.

  3. Glasgow Junior Academic Forum How to get your abstract accepted How to develop a career in research How to get a publishing deal

  4. Abstracts

  5. Abstracts for Scientific Meetings A structured summary of a body of work An exercise in writing with precision and efficiency A beginning a muddle and an end

  6. Abstracts for Scientific Meetings Why bother ?

  7. Abstracts for Scientific Meetings Why bother ? Communication of science

  8. Abstracts for Scientific Meetings Why bother ? (fast) Communication of science

  9. Abstracts for Scientific Meetings Why bother ? (fast) Communication of science

  10. Abstracts for Scientific Meetings Why bother ? Establish a reputation (fast) Communication of science

  11. Abstracts for Scientific Meetings Focus the mind Why bother ? Establish a reputation (fast) Communication of science

  12. Abstracts for Scientific Meetings Focus the mind Why bother ? Establish a reputation (fast) Communication of science Curriculum Vitae

  13. Abstracts for Scientific Meetings To get a publication Focus the mind Why bother ? Establish a reputation (fast) Communication of science Curriculum Vitae

  14. Abstracts for Scientific Meetings To get a publication Focus the mind Learned discussion Why bother ? Establish a reputation (fast) Communication of science Curriculum Vitae

  15. Abstracts for Scientific Meetings To get a publication Focus the mind Learned discussion Why bother ? Establish a reputation (fast) Communication of science Curriculum Vitae Necessary for manuscript

  16. Abstracts for Scientific Meetings To get a publication Focus the mind It beats proper work Learned discussion Why bother ? Establish a reputation (fast) Communication of science Curriculum Vitae Necessary for manuscript

  17. Abstract Selection Process • Abstracts centrally collated • Independent quantitative assessment by “expert(s)” May be single / double blinded “Objective” scoring criteria • Score for selection (oral / poster) determined (varies with number of submissions) approx 33% acceptance rate for international meetings

  18. Abstracts General Points • Should be a “stand alone” piece of work • No new information • No reference to manuscript • Should be written after study complete / after first draft • Clear, short sentences (reviewers not all native English speakers) • Third person, active voice, past tense • Avoid jargon, abbreviations

  19. Abstract Submission GJAF SYMPOSIUM 2010 Title : Authors: Section: Trials □ Science □Epidemiology □ Economics □ Platform: Oral □ Poster □ Introduction Methods Results Conclusion Max words:250

  20. Abstract Submission GJAF SYMPOSIUM 2010 Title : Authors: Section: Trials □ Science □Epidemiology □ Economics □ Platform: Oral □ Poster □ Introduction Methods Results Conclusion Max words:250

  21. Which meeting? Specialist v. Generalist Local v. National v. International

  22. Which meeting? Local v. National v. International

  23. Which meeting? Local v. National v. International

  24. Which meeting? Local v. National v. International Difficulty: Often inclusive Difficulty: < 1/3 accepted

  25. Which meeting? Local v. National v. International Difficulty: Often inclusive Difficulty: < 1/3 accepted ? Abstract published ? Abstract published in high impact journal

  26. Which meeting? Local v. National v. International Difficulty: Often inclusive Difficulty: < 1/3 accepted ? Abstract published ? Abstract published in high impact journal Networking Research profile

  27. Which meeting? Local v. National v. International Difficulty: Often inclusive Difficulty: < 1/3 accepted ? Abstract published ? Abstract published in high impact journal Networking Research profile Small size, useful discussion BIG size

  28. Which meeting? Local v. National v. International £ £

  29. Which meeting? Local v. National v. International £ £ Society travel grants University awards Industry ST / SpR Study budget

  30. An abstract threesome Submission of original research to one local, one national and one international meeting (with one published abstract) is acceptable

  31. Abstract Submission GJAF SYMPOSIUM 2010 Title : Authors: Section: Trials □ Science □Epidemiology □ Economics □ Platform: Oral □ Poster □ Introduction Methods Results Conclusion Max words:250

  32. Title Terry’s brilliant review

  33. Title Terry’s brilliant review Keywords

  34. Title Review of TGF-β in CHD Keywords

  35. Title Review of TGF-β in CHD Keywords Avoid abbreviations

  36. Title Review of Transforming Growth Factor-β in Coronary Heart Disease Keywords Avoid abbreviations

  37. Title Review of Transforming Growth Factor-β in Coronary Heart Disease Keywords Avoid abbreviations Be specific (Include design: avoid review of…; study of…)

  38. Title Systematic review and meta-analysis of serum Transforming Growth Factor-β and association with Coronary Heart Disease Keywords Avoid abbreviations Be specific

  39. Title Systematic review and meta-analysis of serum Transforming Growth Factor-β and association with Coronary Heart Disease Keywords Avoid abbreviations Be specific Be creative - maybe

  40. Title TGF-β or not TGF-β that is the question Keywords Avoid abbreviations Be specific Be creative ?

  41. Title TGF-β or not TGF-β that is the question Keywords Avoid abbreviations Be specific Be creative ?

  42. Title Systematic review and meta-analysis of serum Transforming Growth Factor-β and association with Coronary Heart Disease Keywords Avoid abbreviations Be specific Be creative – maybe Be definitive – if the data allows

  43. Title There is no association between serum Transforming Growth Factor-β and Coronary Heart Disease Systematic review and meta-analysis Keywords Avoid abbreviations Be specific Be creative – maybe Be definitive – if the data allows

  44. Abstract Submission GJAF SYMPOSIUM 2010 Title : Authors: Section: Trials □ Science □Epidemiology □ Economics □ Platform: Oral □ Poster □ Introduction Methods Results Conclusion Max words:250

  45. Authors • Include them all (remember statisticians, original data collection) ….. and let them approve abstract before submission • First author usually presents • Author(s) may need to be member of society for submission • What is your research name ?

  46. Abstract Submission GJAF SYMPOSIUM 2010 Title : Authors: Section: Trials □ Science □Epidemiology □ Economics □ Platform: Oral □ Poster □ Introduction Methods Results Conclusion Max words:250

  47. Section • Some meetings may have only one section • Space devoted to sections may not be equal • Submissions for each section may not be equal • Assessors for each session will differ • Timing of sections may differ • Some meetings have non-research sections (interesting cases)

  48. Abstract Submission GJAF SYMPOSIUM 2010 Title : Authors: Section: Trials □ Science □Epidemiology □ Economics □ Platform: Oral □ Poster □ Introduction Methods Results Conclusion Max words:250

  49. Platform • Always choose oral platforms • Kudos • Better exposure • Publication chances increased • Posters are a hassle • If not successful, abstract will be considered for poster

  50. Abstract Submission GJAF SYMPOSIUM 2010 Title : Authors: Section: Trials □ Science □Epidemiology □ Economics □ Platform: Oral □ Poster □ Introduction Methods Results Conclusion Max words:250

More Related